RESULTADOS INVESTIGACIÓN

Resultados: 118

03. CYP2B6

AMÉRICA CENTRAL

Arenaz I, Vicente J, Fanlo A, Vásquez P, Medina JC, Conde B, González-Andrade  F, Sinués B. Haplotype structure and allele frequencies of CYP2B6 in Spaniards and Central Americans. Fundam Clin Pharmacol. 2010 Apr;24(2):247-53.

04. CYP3A4

ECUADOR

Sinués B, Vicente J, Fanlo A, Mayayo-Sinués E, González-Andrade F, Sánchez-Q D, Martínez-Jarreta B. CYP3A5 3, CYP3A4 1B and MDR1 C3435T genotype distributions in Ecuadorians. Dis Markers. 2008;24(6):325-31.

04. CYP3A4

ESTADOS UNIDOS

Ball SE, Scatina J, Kao J, Ferron GM, Fruncillo R, Mayer P, Weinryb I, Guida M, Hopkins PJ, Warner N, Hall J. Population distribution and effects on drug metabolism of a genetic variant in the 5′ promoter region of CYP3A4. Clin Pharmacol Ther. 1999 Sep;66(3):288-94.

04. CYP3A4

EL SALVADOR

Sinues B, Vicente J, Fanlo A, Vasquez P, Medina JC, Mayayo E, Conde B, Arenaz I, Martinez-Jarreta B. CYP3A5*3 and CYP3A4*1B allele distribution and genotype combinations: differences between Spaniards and Central Americans. Ther Drug Monit. 2007 Aug;29(4):412-6.

04. CYP3A4

ESPAÑA

García-Martín E, Martínez C, Pizarro RM, García-Gamito FJ, Gullsten H, Raunio H, Agúndez JA. CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity. Clin Pharmacol Ther. 2002 Mar;71(3):196-204.

Gervasini G, Vizcaino S, Gasiba C, Carrillo JA, Benitez J. Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between  Spaniards and Other Caucasian populations. Ther Drug Monit. 2005 Dec;27(6):819-21.

Gervasini G, García-Martín E, Ladero JM, Pizarro R, Sastre J, Martínez C, García M, Diaz-Rubio M, Agúndez JA. Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients. BMC Cancer. 2007 Jul 2;7:118.

Sinues B, Vicente J, Fanlo A, Vasquez P, Medina JC, Mayayo E, Conde B, Arenaz I, Martinez-Jarreta B. CYP3A5*3 and CYP3A4*1B allele distribution and genotype combinations: differences between Spaniards and Central Americans. Ther Drug Monit. 2007 Aug;29(4):412-6.

04. CYP3A4

MÉXICO

Gonzalez HM, Romero EM, Peregrina AA, de J Chávez T, Escobar-Islas E, Lozano F, Hoyo-Vadillo C. CYP2C19- and CYP3A4-dependent omeprazole metabolism in West Mexicans. J Clin Pharmacol. 2003 Nov;43(11):1211-5.

Reyes-Hernández OD, Arteaga-Illán G, Elizondo G. Detection of CYP3A4*1B and CYP3A4*2 polymorphisms by RFLP. Distribution frequencies in a Mexican population. Clin Genet. 2004 Aug;66(2):166-8.

Reyes-Hernández OD, Lares-Asseff I, Sosa-Macias M, Vega L, Albores A, Elizondo G. A comparative study of CYP3A4 polymorphisms in Mexican Amerindian and Mestizo populations. Pharmacology. 2008;81(2):97-103.

04. CYP3A4

NICARAGUA

Sinues B, Vicente J, Fanlo A, Vasquez P, Medina JC, Mayayo E, Conde B, Arenaz  I, Martinez-Jarreta B. CYP3A5*3 and CYP3A4*1B allele distribution and genotype combinations: differences between Spaniards and Central Americans. Ther Drug Monit. 2007 Aug;29(4):412-6.

04. CYP3A4

PORTUGAL

Cavaco I, Gil JP, Gil-Berglund E, Ribeiro V. CYP3A4 and MDR1 alleles in a Portuguese population. Clin Chem Lab Med. 2003 Oct;41(10):1345-50.

Oliveira E, Marsh S, van Booven DJ, Amorim A, Prata MJ, McLeod HL. Pharmacogenetically relevant polymorphisms in Portugal. Pharmacogenomics. 2007 Jul;8(7):703-12. doi: 10.2217/14622416.8.7.703.

04. CYP3A4

AMÉRICA CENTRAL

Sinues B, Vicente J, Fanlo A, Vasquez P, Medina JC, Mayayo E, Conde B, Arenaz I, Martinez-Jarreta B. CYP3A5*3 and CYP3A4*1B allele distribution and genotype combinations: differences between Spaniards and Central Americans. Ther Drug Monit. 2007 Aug;29(4):412-6.

05. CYP3A5

ARGENTINA

Larriba J, Imperiali N, Groppa R, Giordani C, Algranatti S, Redal MA. Pharmacogenetics of immunosuppressant polymorphism of CYP3A5 in renal transplant recipients. Transplant Proc. 2010 Jan-Feb;42(1):257-9.

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

ACEPTAR
Aviso de cookies